Your shopping cart is currently empty

DSPE-SPDP is a reactive phospholipid molecule. In aqueous environments, DSPE-SPDP can orient itself to form lipid bilayers or participate in the construction of lipid nanoparticles (LNPs). The SPDP functional group possesses disulfide exchange activity, allowing for the covalent conjugation of sulfhydryl-containing (-SH) biomolecules, such as antibodies, peptides, or siRNAs, to the surface of nanocarriers under physiological conditions.


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $195 | - | In Stock | |
| 5 mg | $483 | - | In Stock | |
| 10 mg | $691 | - | In Stock | |
| 25 mg | $1,080 | - | In Stock | |
| 50 mg | $1,490 | - | In Stock | |
| 100 mg | $1,960 | - | In Stock |
| Description | DSPE-SPDP is a reactive phospholipid molecule. In aqueous environments, DSPE-SPDP can orient itself to form lipid bilayers or participate in the construction of lipid nanoparticles (LNPs). The SPDP functional group possesses disulfide exchange activity, allowing for the covalent conjugation of sulfhydryl-containing (-SH) biomolecules, such as antibodies, peptides, or siRNAs, to the surface of nanocarriers under physiological conditions. |
| In vitro | In vitro nanomedicine studies utilize DSPE-SPDP as a functional lipid component. Research demonstrates that nanoscale coordination polymers (NCPs) constructed using DSPE-SPDP can successfully conjugate targeting ligands, facilitating the synergistic delivery of chemotherapeutics and siRNAs in cisplatin-resistant ovarian cancer cell lines, such as OVCAR-3 [1]. |
| In vivo | In vivo, nanocarriers surface-modified with DSPE-SPDP exhibit excellent stability in blood circulation. In animal models bearing cisplatin-resistant ovarian cancer xenografts, this delivery system significantly reduces tumor burden and eradicates resistant tumor lesions through the co-delivery of drugs and genetic materials [1]. |
| Molecular Weight | 945.34 |
| Formula | C49H89N2O9PS2 |
| Cas No. | 144735-79-5 |
| Smiles | [C@@H](COP(OCCNC(CCSSC1=CC=CC=N1)=O)(=O)O)(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.